Storm Therapeutics

company

About

Targeting pathways that modify RNA to deliver novel cancer therapeutics

Details

Last Funding Type
Series B
Last Funding Money Raised
$30M
Industries
Biotechnology,Health Care,Medical,Therapeutics
Founded date
Jan 1, 2015
Number Of Employee
11 - 50
Operating Status
Active
Legal Name
STORM Therapeutics Limited
Also Known As
Iceni Therapeutics

Targeting pathways that modify RNA to deliver novel cancer therapeutics.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
7
$30M £30.24M
Storm Therapeutics has raised a total of $30M £30.24M in funding over 2 rounds. Their latest funding was raised on Dec 14, 2022 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 14, 2022 Series B $30M 8 Cambridge Innovation Capital
Fast Track Initiative, Inc.
M Ventures
Pfizer Venture Investments
Taiho Ventures
UTokyo Innovation Platform
Detail
May 3, 2022 Grant 1 Innovate UK Detail
May 20, 2019 Series A £14M 6 Seroba Life Sciences Detail
Sep 3, 2018 Grant £240K 1 Innovate UK Detail
Jan 8, 2018 Series A £4M 1 Taiho Ventures Detail

Employee Profiles

Number of Employee Profiles
8
Storm Therapeutics has 8 current employee profiles, including Executive Gerald McMahon
Executive
Board member
Board member
Board member
Board member